Literature DB >> 19628075

Targeting the gut barrier: identification of a homing peptide sequence for delivery into the injured intestinal epithelial cell.

Todd W Costantini1, James G Putnam, Ritsuko Sawada, Andrew Baird, William H Loomis, Brian P Eliceiri, Vishal Bansal, Raul Coimbra.   

Abstract

BACKGROUND: Severe injury results in intestinal barrier dysfunction that may be responsible for significant morbidity and mortality. We postulated that mining a peptide library that was displayed on phage would identify peptide sequences that bind and internalize into the gut epithelium following injury.
METHODS: We utilized a severe full thickness burn in mice as a model of severe injury. Candidate peptides were identified by screening 10(12) phage displaying unique peptide sequences. In vivo assessment was performed by injecting targeted phage into the lumen of a segment of distal ileum following burn injury, then analyzed for uptake of peptide sequence using quantitative polymerase chain reaction (PCR), DNA sequencing, and confocal microscopy of the peptide bound to quantum dots (Qdots).
RESULTS: Phage screening identified the peptide sequence T18 (LTHPQDSPPASA) as an optimal candidate for in vivo testing. PCR of intestinal cells following injury showed a higher level of T18 sequence when compared to untargeted phage. Confocal microscopy of the peptide sequence bound to Qdots showed internalization into gut mucosa following injury.
CONCLUSION: We have identified a peptide sequence that targets the injured intestinal epithelium and may allow for the development of targeted therapies to attenuate inflammation, or other pathologic conditions of the small bowel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19628075      PMCID: PMC4251594          DOI: 10.1016/j.surg.2009.05.007

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  25 in total

1.  Receptor-mediated gene transfer by phage-display vectors: applications in functional genomics and gene therapy.

Authors:  D Larocca; A Baird
Journal:  Drug Discov Today       Date:  2001-08-01       Impact factor: 7.851

2.  Identification of peptide sequences that induce the transport of phage across the gastrointestinal mucosal barrier.

Authors:  Daniel M Duerr; Stephen J White; Hermann J Schluesener
Journal:  J Virol Methods       Date:  2004-03-15       Impact factor: 2.014

Review 3.  Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route.

Authors:  Conrad E Johanson; John A Duncan; Edward G Stopa; Andrew Baird
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

4.  Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment.

Authors:  Jessica A Clark; Sarah M Doelle; Melissa D Halpern; Tara A Saunders; Hana Holubec; Katerina Dvorak; Scott A Boitano; Bohuslav Dvorak
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-06-22       Impact factor: 4.052

5.  Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries.

Authors:  M A Barry; W J Dower; S A Johnston
Journal:  Nat Med       Date:  1996-03       Impact factor: 53.440

6.  Identification of ligands binding specifically to inflammatory intestinal mucosa using phage display.

Authors:  Tamaki Takagi; Tomiyasu Arisawa; Kazumasa Yamamoto; Ichiro Hirata; Hiroshi Nakano; Makoto Sawada
Journal:  Clin Exp Pharmacol Physiol       Date:  2007-04       Impact factor: 2.557

7.  LIGHT signals directly to intestinal epithelia to cause barrier dysfunction via cytoskeletal and endocytic mechanisms.

Authors:  Brad T Schwarz; Fengjun Wang; Le Shen; Daniel R Clayburgh; Liping Su; Yingmin Wang; Yang-Xin Fu; Jerrold R Turner
Journal:  Gastroenterology       Date:  2007-02-27       Impact factor: 22.682

8.  A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair.

Authors:  Cynthia L Leaphart; Jaime Cavallo; Steven C Gribar; Selma Cetin; Jun Li; Maria F Branca; Theresa D Dubowski; Chhinder P Sodhi; David J Hackam
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

9.  Role of p38 MAPK in burn-induced intestinal barrier breakdown.

Authors:  Todd W Costantini; Carrie Y Peterson; Lauren Kroll; William H Loomis; Brian P Eliceiri; Andrew Baird; Vishal Bansal; Raul Coimbra
Journal:  J Surg Res       Date:  2009-05-03       Impact factor: 2.192

10.  Systemic not just mesenteric lymph causes acute lung injury following hemorrhagic shock.

Authors:  Lawrence N Diebel; David M Liberati; Anna M Ledgerwood; Charles E Lucas
Journal:  Surgery       Date:  2008-10       Impact factor: 3.982

View more
  11 in total

Review 1.  Combinatorial peptide libraries: mining for cell-binding peptides.

Authors:  Bethany Powell Gray; Kathlynn C Brown
Journal:  Chem Rev       Date:  2013-12-03       Impact factor: 60.622

2.  A Human-Specific α7-Nicotinic Acetylcholine Receptor Gene in Human Leukocytes: Identification, Regulation and the Consequences of CHRFAM7A Expression.

Authors:  Todd W Costantini; Xitong Dang; Maryana V Yurchyshyna; Raul Coimbra; Brian P Eliceiri; Andrew Baird
Journal:  Mol Med       Date:  2015-04-03       Impact factor: 6.354

Review 3.  CHRFAM7A, a human-specific and partially duplicated α7-nicotinic acetylcholine receptor gene with the potential to specify a human-specific inflammatory response to injury.

Authors:  Todd W Costantini; Xitong Dang; Raul Coimbra; Brian P Eliceiri; Andrew Baird
Journal:  J Leukoc Biol       Date:  2014-12-03       Impact factor: 4.962

4.  Intravenous phage display identifies peptide sequences that target the burn-injured intestine.

Authors:  Todd W Costantini; Brian P Eliceiri; James G Putnam; Vishal Bansal; Andrew Baird; Raul Coimbra
Journal:  Peptides       Date:  2012-08-30       Impact factor: 3.750

5.  Targeting choroid plexus epithelia and ventricular ependyma for drug delivery to the central nervous system.

Authors:  Ana Maria Gonzalez; Wendy E Leadbeater; Michael Burg; Karen Sims; Tetsuya Terasaki; Conrad E Johanson; Edward G Stopa; Brian P Eliceiri; Andrew Baird
Journal:  BMC Neurosci       Date:  2011-01-07       Impact factor: 3.288

6.  Ecological basis for rational phage therapy.

Authors:  A V Letarov; A K Golomidova; K K Tarasyan
Journal:  Acta Naturae       Date:  2010-04       Impact factor: 1.845

Review 7.  Phage therapy: What factors shape phage pharmacokinetics and bioavailability? Systematic and critical review.

Authors:  Krystyna Dąbrowska
Journal:  Med Res Rev       Date:  2019-03-19       Impact factor: 12.944

Review 8.  Interactions between Bacteriophage, Bacteria, and the Mammalian Immune System.

Authors:  Jonas D Van Belleghem; Krystyna Dąbrowska; Mario Vaneechoutte; Jeremy J Barr; Paul L Bollyky
Journal:  Viruses       Date:  2018-12-25       Impact factor: 5.048

9.  Discovery of a Biological Mechanism of Active Transport through the Tympanic Membrane to the Middle Ear.

Authors:  Arwa Kurabi; Kwang K Pak; Marlen Bernhardt; Andrew Baird; Allen F Ryan
Journal:  Sci Rep       Date:  2016-03-07       Impact factor: 4.379

Review 10.  Pf Bacteriophage and Their Impact on Pseudomonas Virulence, Mammalian Immunity, and Chronic Infections.

Authors:  Patrick R Secor; Elizabeth B Burgener; M Kinnersley; Laura K Jennings; Valery Roman-Cruz; Medeea Popescu; Jonas D Van Belleghem; Naomi Haddock; Conner Copeland; Lia A Michaels; Christiaan R de Vries; Qingquan Chen; Julie Pourtois; Travis J Wheeler; Carlos E Milla; Paul L Bollyky
Journal:  Front Immunol       Date:  2020-02-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.